Introduction: in September 2001, the domestic glimepiide tablet dibei was approved by the state drug administration and it belongs to the second class new drug in the country, and began to be sold in the domestic market in November.It has been well received by clinical experts and patients since its sale for 3 years.
Indications: Type 2 diabetes.
Usage and dosage: refer to instructions or doctor's advice for details
Adverse Reaction: See the instructions for details
Contraindications: It is contraindicated in people with known allergy to any ingredient in glimepiride, other sulfonylureas, sulfonamides or excipients;It is contraindicated for patients with previous ketoacidosis, diabetic ketoacidosis, pre-diabetic coma or diabetic coma;Patients with severe liver and renal function impairment are contraindicated.Pregnant and lactating patients are prohibited;
Precautions: See the instructions for details
智藥研習(xí)社官方微信
制藥在線官方微信
2006-2025 上海博華國(guó)際展覽有限公司版權(quán)所有（保留一切權(quán)利）
滬ICP備05034851號(hào)-57
